Imax sees much improved China market in 2025, says Roth MKM

Roth MKM keeps a Buy rating and $28 price target on Imax (IMAX) while noting that the commentary from IMAX China’s CEO, Daniel Manwaring, in an IMAX-sponsored webinar has laid out key reasons for a much improved 2025 box office in China. Local language movies will benefit from bigger budgets and better genre breadth, the Hollywood lineup should have broader appeal, and IMAX is also benefiting from greater interest for premium experiences among consumers, the analyst tells investors in a research note.